Clinical trials
Completed Observational Venous Thrombosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
154 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 8 |
| 2007 | 7 |
| 2008 | 8 |
| 2009 | 7 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 9 |
| 2013 | 6 |
| 2014 | 12 |
| 2015 | 14 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 15 |
| 2021 | 9 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 154 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 10 |
| Brigham and Women's Hospital | 8 |
| Centre Hospitalier Universitaire de Saint Etienne | 4 |
| Ottawa Hospital Research Institute | 4 |
| Centre Hospitalier Universitaire de Nīmes | 3 |
| GlaxoSmithKline | 3 |
| Mayo Clinic | 3 |
| McMaster University | 3 |
| University Hospital, Brest | 3 |
| Azienda Sanitaria Locale ASL 6, Livorno | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Venous Thrombosis | 154 |
| Pulmonary Embolism | 72 |
| Venous Thromboembolism | 47 |
| Thrombosis | 18 |
| Atrial Fibrillation | 16 |
| Thromboembolism | 12 |
| Neoplasms | 11 |
| Hemorrhage | 9 |
| COVID-19 | 8 |
| Embolism and Thrombosis | 6 |
Trials
Showing 1 to 25 of 154. Each trial links to its page on Pharma Observatory.
54 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.